Oliver explored the future of data-driven decision-making on the Affinity Stage @ Biopharma & Life Sciences Connected Live, UK.
Oliver's engaging talk looked into how assistive intelligence is transforming the way we interact with and interpret data in the life sciences sector, and shared how human-AI collaboration can empower teams to make faster, smarter decisions—enhancing research, streamlining operations, and opening new doors for innovation in biopharma.
The expert panel is dove into how Artificial Intelligence is reshaping the biopharma and life sciences landscape—from early-stage discovery to advanced analytics and predictive modelling.
Panellists include: 🔹 Eoin Carroll, CEO, Decision Analytics 🔹 Oliver King-Smith, Founder, smartR AI 🔹 Mohammad Rajput, Strategy & Innovation, Sia
Together, they unpacked the opportunities, risks, and regulatory considerations involved in scaling AI solutions across complex pharma environments.